1. Home
  2. CGEN vs CXDO Comparison

CGEN vs CXDO Comparison

Compare CGEN & CXDO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CGEN
  • CXDO
  • Stock Information
  • Founded
  • CGEN 1993
  • CXDO 1995
  • Country
  • CGEN Israel
  • CXDO United States
  • Employees
  • CGEN N/A
  • CXDO N/A
  • Industry
  • CGEN Biotechnology: Biological Products (No Diagnostic Substances)
  • CXDO Telecommunications Equipment
  • Sector
  • CGEN Health Care
  • CXDO Telecommunications
  • Exchange
  • CGEN Nasdaq
  • CXDO Nasdaq
  • Market Cap
  • CGEN 135.6M
  • CXDO 118.9M
  • IPO Year
  • CGEN 2000
  • CXDO 1998
  • Fundamental
  • Price
  • CGEN $1.47
  • CXDO $4.45
  • Analyst Decision
  • CGEN Strong Buy
  • CXDO Strong Buy
  • Analyst Count
  • CGEN 1
  • CXDO 2
  • Target Price
  • CGEN $4.00
  • CXDO $8.75
  • AVG Volume (30 Days)
  • CGEN 268.4K
  • CXDO 125.3K
  • Earning Date
  • CGEN 05-19-2025
  • CXDO 05-06-2025
  • Dividend Yield
  • CGEN N/A
  • CXDO N/A
  • EPS Growth
  • CGEN N/A
  • CXDO N/A
  • EPS
  • CGEN N/A
  • CXDO 0.06
  • Revenue
  • CGEN $27,864,000.00
  • CXDO $60,838,000.00
  • Revenue This Year
  • CGEN $11.81
  • CXDO $13.25
  • Revenue Next Year
  • CGEN $28.37
  • CXDO $11.35
  • P/E Ratio
  • CGEN N/A
  • CXDO $73.50
  • Revenue Growth
  • CGEN N/A
  • CXDO 14.36
  • 52 Week Low
  • CGEN $1.13
  • CXDO $2.92
  • 52 Week High
  • CGEN $2.66
  • CXDO $7.34
  • Technical
  • Relative Strength Index (RSI)
  • CGEN 49.50
  • CXDO 40.51
  • Support Level
  • CGEN $1.13
  • CXDO $4.40
  • Resistance Level
  • CGEN $1.35
  • CXDO $4.80
  • Average True Range (ATR)
  • CGEN 0.11
  • CXDO 0.40
  • MACD
  • CGEN 0.03
  • CXDO 0.02
  • Stochastic Oscillator
  • CGEN 85.00
  • CXDO 46.98

About CGEN Compugen Ltd.

Compugen Ltd is a clinical-stage therapeutic discovery and development company utilizing its broadly applicable predictive computational discovery capabilities to identify novel drug targets and new biological pathways to develop therapeutics in the field of cancer immunotherapy. Its immuno-oncology pipeline consists of four clinical-stage programs, targeting immune checkpoints the company discovered computationally, COM701, COM902 and bapotulimab. The company's therapeutic pipeline of early-stage immuno-oncology programs consists of programs aiming to address various mechanisms of immune resistance, including myeloid targets.

About CXDO Crexendo Inc.

Crexendo Inc is a provider of cloud communications, UCaaS, call centers, collaboration services, and other cloud business services. The company operates through two segments: Cloud telecommunications and Software Solutions. Its cloud telecommunications segment offers hardware, software, and unified communication solutions for businesses using IP or cloud technology over any high-speed Internet connection. The Software Solutions segment is involved in revenue generation from software licenses, software maintenance support, and professional services. It generates subscription and maintenance support revenue from customer support and other supportive services. The company offers warranties on its products. It derives a majority of its revenue from the Cloud telecommunications segment.

Share on Social Networks: